Vaxcyte names John Markels to board as Heath Lukatch retires
PCVX•Board change effective July 16, 2026
- Vaxcyte board member Heath Lukatch will retire effective July 16, 2026.
- John Markels was appointed to the board as a Class II director effective July 16, 2026; term runs through the 2028 annual meeting.
- Markels also joins the board’s audit committee, plus the compensation committee.
